Both drugs, through independent studies, showed the same pattern: essentially no transfer into breast milk
Responses may vary depending on: Research amount Escalation speed Protocol duration Individual sensitivity Nutrition and caloric intake Concurrent research compounds Commonly Reported Research Observations Nausea Reduced appetite Fullness or bloating Constipation Diarrhea Heartburn or reflux Fatigue or reduced energy levels Headaches Mild stomach discomfort Additional Reported Research Observations Temporary dizziness Food aversions Increased sensitivity to certain foods Dehydration associated with insufficient fluid intake Administration-Escalation Considerations Many research protocols utilize gradual administration escalation, as rapid increases may increase the likelihood of gastrointestinal discomfort and appetite-related side effects
Alo Protocol for GLP-1 Users (The Optimizer) Even though the muscle loss isn't "dangerous," as your doctor, I still want to optimize your body composition
If youve been looking into weight loss injections, theres a good chance youve heard of Semaglutide (sold as Ozempic or Wegovy) and Tirzepatide (youve probably seen it as Zepbound or Mounjaro)
Reports of structural changes are highly variable and it is not clear if these represent a reliable and reproducible feature after LDSF [28], these results should be interpreted with caution
According to the NHS, treating deficiency early prevents long-term complications